The company's system includes EMBRACE, a transcatheter anti-embolic filter that fits perfectly with the aortic wall and covers all three main branches of the aortic arch, and GEMINI, a transcatheter debridement device that uses ultrasound waves to restore the functionality of the patient's valve. AorticLab is committed to providing medical and technological innovations to boost the success of restoring the aortic valve function, and their devices have been proven to be safe and effective in clinical trials. With their advanced transcatheter solutions, AorticLab aims to improve the quality of life for patients with aortic valve stenosis.